| 前收市價 | 0.7000 |
| 開市 | 0.6900 |
| 買盤 | 0.6759 x 100 |
| 賣出價 | 0.6886 x 100 |
| 今日波幅 | 0.6800 - 0.7264 |
| 52 週波幅 | 0.5000 - 4.6700 |
| 成交量 | |
| 平均成交量 | 629,290 |
| 市值 | 37.409M |
| Beta 值 (5 年，每月) | 0.70 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -2.1900 |
| 業績公佈日 | 2024年5月13日 - 2024年5月17日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 5.23 |
InvestorPlace7 F-Rated Stocks to Sell in March 2024
Are you feeling good about the stock market? You should. The market continued to show strength in early 2024, which is all the more reason to rid your portfolio of F-rated stocks. When the stock market’s this strong, it’s no time to consolidate your positions around bottom-dwellers at bargain prices. This is a time to capitalize on the market’s momentum and look for stocks that are already strong. So far in 2024, the Dow Jones Industrial Average is up more than 2%, topping 38,000. The Nasdaq Com
Insider MonkeyCara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript March 4, 2024 Cara Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.59 EPS, expectations were $-0.57. CARA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing […]
ZacksCara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
Cara (CARA) delivered earnings and revenue surprises of -3.51% and 28.60%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
